Payment overview · 2025
General Payments
$62.72
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael P Bernard, MD
Allopathic & Osteopathic Physicians|Internal Medicine · KNOXVILLE, TN · NPI 1386633949
Verified facts
What the public records show
CMS Open Payments records show Michael P Bernard, MD received $62.72 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$62.72 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $62.72 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AFFERA MAPPING SYSTEM Normalized: affera mapping system |
Device | Medtronic, Inc. | $62.72 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 768 | 234 |
| Levothyroxine Sodium | Levothyroxine Sodium | 598 | 162 |
| Atorvastatin Calcium | Atorvastatin Calcium | 537 | 146 |
| Pantoprazole Sodium | Pantoprazole Sodium | 474 | 169 |
| Lisinopril | Lisinopril | 438 | 120 |
| Amlodipine Besylate | Amlodipine Besylate | 437 | 131 |
| Losartan Potassium | Losartan Potassium | 369 | 91 |
| Gabapentin | Gabapentin | 225 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 220 | 66 |
| Fluticasone Propionate | Fluticasone Propionate | 214 | 85 |
| Metformin Hcl | Metformin Hcl | 205 | 54 |
| Meloxicam | Meloxicam | 204 | 68 |
| Eliquis | Apixaban | 196 | 43 |
| Famotidine | Famotidine | 194 | 65 |
| Tamsulosin Hcl | Tamsulosin Hcl | 184 | 55 |
| Trazodone Hcl | Trazodone Hcl | 174 | 44 |
| Hydrochlorothiazide | Hydrochlorothiazide | 163 | 55 |
| Tramadol Hcl | Tramadol Hcl | 162 | 41 |
| Montelukast Sodium | Montelukast Sodium | 155 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 149 | 48 |
| Mounjaro | Tirzepatide | 125 | 20 |
| Furosemide | Furosemide | 124 | 35 |
| Omeprazole | Omeprazole | 123 | 30 |
| Celecoxib | Celecoxib | 119 | 46 |
| Donepezil Hcl | Donepezil Hcl | 116 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 113 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 28 |
| Glimepiride | Glimepiride | 103 | 32 |
| Alprazolam | Alprazolam | 102 | 32 |
| Baclofen | Baclofen | 102 | 51 |
| Metformin Hcl Er | Metformin Hcl | 101 | 30 |
| Simvastatin | Simvastatin | 101 | 26 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 94 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 92 | 28 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 92 | 33 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 90 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 87 | 29 |
| Atenolol | Atenolol | 86 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 83 | 22 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 83 | 31 |
| Carvedilol | Carvedilol | 82 | 18 |
| Allopurinol | Allopurinol | 80 | 24 |
| Alendronate Sodium | Alendronate Sodium | 79 | 32 |
| Spironolactone | Spironolactone | 79 | 30 |
| Jardiance | Empagliflozin | 76 | 16 |
| Lamotrigine | Lamotrigine | 76 | 20 |
| Azelastine Hcl | Azelastine Hcl | 70 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 67 | 12 |
| Synthroid | Levothyroxine Sodium | 66 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 65 | 22 |
| Cephalexin | Cephalexin | 64 | 39 |
| Sertraline Hcl | Sertraline Hcl | 63 | 20 |
| Methylprednisolone | Methylprednisolone | 61 | 53 |
| Myrbetriq | Mirabegron | 59 | 12 |
| Ozempic | Semaglutide | 59 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 58 | 50 |
| Potassium Chloride | Potassium Chloride | 58 | 17 |
| Propranolol Hcl Er | Propranolol Hcl | 58 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 16 |
| Buspirone Hcl | Buspirone Hcl | 54 | 15 |
| Bupropion Xl | Bupropion Hcl | 52 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 51 | 18 |
| Pregabalin | Pregabalin | 49 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 49 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 47 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | suppressed |
| Lorazepam | Lorazepam | 47 | 15 |
| Valsartan | Valsartan | 46 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 44 | 15 |
| Labetalol Hcl | Labetalol Hcl | 43 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 43 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 42 | 14 |
| Memantine Hcl | Memantine Hcl | 42 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 40 | 22 |
| Prednisone | Prednisone | 39 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | suppressed |
| Finasteride | Finasteride | 38 | 11 |
| Mirtazapine | Mirtazapine | 38 | 15 |
| Xarelto | Rivaroxaban | 38 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | suppressed |
| Bumetanide | Bumetanide | 34 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | 13 |
| Clonidine | Clonidine | 32 | suppressed |
| Ezetimibe | Ezetimibe | 32 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 32 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 32 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 31 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 12 |
| Novolog Flexpen | Insulin Aspart | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 28 |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 25 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 22 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 20 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 18 |
| Naloxone Hcl | Naloxone Hcl | 19 | 12 |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Telmisartan | Telmisartan | 18 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Cromolyn Sodium | Cromolyn Sodium | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Azithromycin | Azithromycin | 13 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Teriparatide | Teriparatide | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 12 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $62.72 · 1 records | Medtronic, Inc. | AFFERA MAPPING SYSTEM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error